Last updated October 16, 2026

AWLabs

Monitoring indoor air and triggering responses to changing air conditions

Infectious DiseaseProvider WorkflowPreventive Health

Airborne microorganisms can cause infections in susceptible patients. Dust, water, equipment and construction materials can bring microbes into healthcare facilities, where they may multiply and later enter the air. Some infectious particles can remain suspended and travel long distances.

AWLabs provides AirShield, an indoor-air control system combining sensors, predictive analysis and automated responses. Designed for hospitals, labs and other sensitive settings, it continuously monitors air conditions and triggers countermeasures.

Investor Signals

What stands out about AWLabs

Interested in More Startups Like AWLabs?

Get a curated pipeline of healthcare and life sciences startups aligned with your investment thesis.

Get Deal Flow

Get the DealBio Pulse

Weekly insights on health and longevity startups, standout founders, key markets, and notable exits.

You can unsubscribe at any time.